MedPath

AG-181

Generic Name
AG-181

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

Phase 1
Recruiting
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2024-02-29
Last Posted Date
2025-03-28
Lead Sponsor
Agios Pharmaceuticals, Inc.
Target Recruit Count
120
Registration Number
NCT06286033
Locations
🇺🇸

ICON 1255 East 3900 South, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath